Otros idiomas Azitra, Inc.

Acciones

AZTR

US05479L1044

Mercado cerrado - Nyse Otros sitios de cotización 22:10:00 23/05/2024			Varia. Cinco días.	Varia. 1 de enero.
0,2021 ^USD	+0,95 %		+1,92 %	-78,03 %

10/05	Azitra, Inc. Anuncia Datos Preclínicos Positivos de ATR-12 y Diseño Clínico en el Síndrome de Netherton Presentados en la Reunión Anual de la ASGCT	CI
09/05	Azitra, Inc. informa de los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Azitra Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting	20/05
Azitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting	17/05
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting	13/05
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting	10/05
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting	10/05
Azitra, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Azitra, Inc. Announces Q1 2024 Financial Results and Provides Business Updates	09/05
Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting	22/04
Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting	22/04
Azitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024	18/04
Azitra, Inc. Announces Full Year 2023 Financial Results and Provides Business Updates	15/03
Azitra, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	15/03
Azitra Closes $5 Million Public Offering	16/02
Azitra, Inc. Announces Closing of Public Offering	16/02
Top Midday Decliners	14/02
Azitra Prices Stock Offering at $0.30 a Share	14/02
Azitra, Inc. Announces Pricing of Public Offering	14/02
Azitra Launches Common Stock Offering; Shares Drop	19/01
Azitra, Inc. Strengthens Intellectual Property Portfolio with Newly Granted Patent in the US	16/01
Azitra, Inc. to Present at Biotech Showcase 2024 and the Dermatology Summit 2024, Alongside the J.P. Morgan Annual Healthcare Conference	03/01

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Azitra, Inc.

Acciones

AZTR

US05479L1044

Otros idiomas

Filtros